TY  - BOOK
AU  - Ruediger Mueller
AU  - Johannes von Kempis
TI  - Clinical Trials in Rheumatology
SN  - 1849963843
U1  - 616.724 
PY  - 2010///
CY  - Division of Rheumatology and Rehabilitation Department of Internal Medicine Kantonsspital St. Gallen Switzerland
PB  - Springer Science & Business Media
KW  -  
N1  - Contents:

Rheumatoid Arthritis

Ankylosing Spondylitis

Psoriatic Arthritis

Systemic Lupus Erythematosus

Antiphospholipid Syndrome

Progressive Systemic Sclerosis

Raynauds Phenomenon

DermatoPolymyositis

Takayasu Arteritis

Giant Cell Arteritis

Polymyalgia Rheumatica

ANCAAssociated Vasculitis Churg Strauss syndrome Polyarteritis Nodosa and other vasculitic entities

Purpura Schoenlein Henoch

Morbus Behçet

Abbreviations

Index

Sjögrens Syndrome

N2  - A huge number of therapeutic studies has been published in rheumatology and clinical immunology. This number grows substantially by the year. As such, it becomes increasingly difficult to keep track of this multitude of studies and the ensuing therapeutic trends. Further to this, a particular study can be referred to in a variety of ways, either as a shortened version of the title or an acronym, adding to the confusion. The book Clinical Trials in Rheumatology provides a summary of the important studies in the field for easy reference. Every study is shown with name, acronym (if in existence), authors, complete citation, study design, results, and summary. An acronym finder is supplied at the beginning of the book. This book is a valuable reference tool for rheumatologists and other clinical specialties, as well as for research scientists interested in immunomodulatory and selected other drug therapies in rheumatologic diseases; Common terms and phrases: 12 months abatacept ACR 20 ACR Adalimumab anakinra Arthritis Rheum Authors Publication Follow bosentan Change ciclosporin clinical combination comorbidity Concomitant medication continued corticosteroids cyclophosphamide discontinued disease activity DMARDs dose double-blind duration early effective efficacy Etanercept Follow up Note function global assessment gold Headache Hypertension iloprost improvement increased infection Infliximab joint count lupus mean methotrexate methylprednisolone mg ambrisentan mg ETN mg/day mg/dL mg/kg mg/kg/day mg/L mg/week mm/h months Morning stiffness Nausea Note Adverse events oral pain Patients Authors Publication patients with active placebo prednisolone prednisone Previous medication pulses RA patients randomized reduced relapse remission response Result Patients Authors rheumatoid arthritis score severe skin steroids Substance Result Patients Sulfasalazine swollen joints symptoms syndrome systemic tacrolimus Tapered tender joints therapy tocilizumab treated treatment Trial Substance Result weeks
ER  -